EyePoint EYPT
NASDAQ EYPT
$0.36 +0.00 (+0.53%)
At close: Nov 9, 2026 · 4:00 PM EST

EyePoint (EYPT) Non-Current Deferred Tax Liability (2011)

Updated

EyePoint's Non-Current Deferred Tax Liability was $13,000 in Q4 2011.

Analysis

EyePoint (EYPT) Non-Current Deferred Tax Liability (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 EyePoint 31.41 Mn -881.72 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 13,000.00
API Access

EyePoint Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=EYPT&period=max&api_key=YOUR_API_KEY